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ABSTRACT
Melatonin (MT) (N-acetyl-5-methoxytryptamine) is a lipophilic and hydrophilic indoleamine
with various physiologic functions MT presents in all cells and tissues and distributes in all cell
compartments. Liver is the only organ of circulating MT metabolism. The roles of MT in various
liver pathologies have been extensively studied, and it is believed that oxidative stress (OS) and
lipid peroxidation (LPO) are the key causing factors of almost all conditions compromising liver
function, including nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH),
diabetes, liver fibrosis and cirrhosis. MT improves energy production and reduces apoptosis OS
and LPO in liver. MT protects liver against OS through multiple ways: inhibition of inflammatory
cytokines, direct scavenge of free radicals, stimulation of antioxidant enzymes, decrease of
mitochondrial electron leakage and synergistic function with other classical antioxidants.
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INTRODUCTION
Melatonin and liver function
Melatonin (MT) (N-acetyl-5-
methoxytryptamine) is a derivative of tryptophan
through the serotonin pathway, and synthesized or
present in variety of organs, such as pineal gland
and gastrointestinal tract1-3. MT is a highly lipophilic
and quite hydrophilic indoleamine product. MT is
capable of interacting with lipid bilayers, crossing
biological membranes and reaching all cellular
compartments due to its high lipophilicity and rather
small size1,4. MT is serves as an autacoid factor with
amphiphilicity and restricted toxicity even at high
concentrations of administration. MT has the
maximum secretion levels during the dark period of
light/dark cycle, and the diurnal fluctuation of this
hormone is reflected in its plasma level5, 6. MT initially
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found to control circadian, and has functional
interactions with the circadian system and the
neuroendocrine axis. Besides its multi-faceted free
radical scavenging function, MT acts as antioxidant,
gene regulator, immunomodulator, anti-apoptotic,
anti-inflammatory, anti-gonadotropic, cytoprotective
and oncostatic agent as well as a thermoregulator
hormone2,6. Target cells have membrane receptors
for MT. Circadian control and antioxidant functions
of this hormone are applied in a receptor-mediated
manner. There are three receptors for MT: MT1 and
MT2, which control various processes including cell
proliferation, arterial vasoconstriction and metabolic
functions, and also MT3, probably involves in cellular
redox status regulation1, 7, 8. By using 2-1251-
iodomelatonin (1251-aMT), cell nuclei proteins were
identified to be in association with MT; 2-1251-aMT
has the high affinity in binding mouse hepatocyte
membrane preparations. Nucleus binding sites may
be a physiological MT receptor and the target for
intracellular function of MT2, 7. The MT receptor type
on mouse hepatocyte is of MT1 subclass, specifically
MT1b. Local secretion of MT seems to modulate the
action of gastrointestinal system, including liver, and
that MT probably acts as a mediator in inter-organ
communication between liver and gut4, 9, 10. Liver is
one of the organs in the body for having high activities
of antioxidant enzymes, and it is the solely organ in
metabolism of circulating MT that by in turn regulates
liver metabolism of carbohydrates and lipids. MT
preserves glycogen stores, improves liver fatty
changes, modulates liver concentrations of glucagon
and insulin receptors, attenuates plasma cholesterol
levels, induces gap junction expression and inhibits
hepatocyte proliferation; inhibition of hepatocyte
proliferation is to protect these cells against oxidative
stress (OS)2, 8, 11. MT metabolites still have antioxidant
activity, as 6-hydroxymelatonin sulfate scavenges
free radicals. MT concentration in gastrointestinal
tract is several hundred times more than its level in
pineal gland2, 10, 12. MT has the highest concentration
in the hepatobiliary system, namely liver, portal
circulation and bile, where its level in bile is 1000-
fold higher than blood levels during daytime and the
concentration of MT in bile is 6 times higher than the
concentration in tissue5, 7, 12.
MT distribution and metabolism in liver
MT has the significant higher content in
the gut than in the pineal gland. MT has the
nocturnal pattern of secretion over 8 h, and its
pharmacological doses have no significant side
effects, as 1200 mg/kg of MT has been used in
human subjects without sings of toxicit(8, 11, 13. Levels
of MT are associated with various disorders and
metabolic disturbances. MT has the highest level
in serum. Serum MT concentrations are reduced
by continuous light exposure 11, 14. Serum levels of
MT in mice oscillate from 160 pm per day to 1800
pm per night, which represents about 32-360 pg/
ml. In human plasma levels of MT during the night
is exceeded 55 pg/ml, and in the morning hours is
in the range of 20 pg/ml. Daily production of normal
MT in human, male subjects, is 28.8 µg, and daily
excretion of MT from the bile into the intestinal tract
in human subjects is about 51 ng3, 12, 15. Increased
systemic levels of MT has been documented
following tryptophan administration in rats, pigs and
cheeks, and increased plasma levels of MT has
been attested following food restriction in human
subjects. In humans total serum antioxidative
capability correlates well with serum MT levels 2, 13.
In human the peak MT serum level after
administration of 2 mg of MT is around 1-2 hours
and after administration of 80 mg it rose from 350 to
1000 times over its concentration during night-time.
Dietary MT results in a notable increase in MT
levels, and has the greatest effects in middle-aged
mice  (1). MT is metabolically degraded at the site
of production, and circulating MT in metabolically
degraded in liver (2). When oxidized, MT is not easily
reduced and is not implicated in regenerating
processes which may give rise to toxic recycling
and free radicals formation (3). Instead, MT, upon
oxidation, converts to antioxidant compounds, such
as N1-acetyl-5-methoxykynuramine, N1-acetyl-N2-
formyl-5-methoxy-kynuramine (AFMK) and cyclic
3-hydroxymelatonin (4). Cytochrome c, reactive
oxygen species (ROS) and myeloperoxidase (MPO)
could mediate MT oxidation to AFMK; degradation
of AFMK to N1-acetyl- 5-methoxykynuramine (AMK)
is carried out by both arylamine formamidase and
catalase (CAT) (2). Semak et al indicated that
microsomal cytochrome P450
s
 are involved in
conversion of MT into O-demethylation and
hydroxylation at positions 2 and 6 as well as AFMK,
and mitochondrial cytochrome P450
s
 are involved
in conversion of MT into 2-hydroxymelatonin, N-
acetylserotonin, AFMK, 6-hydroxymelatonin. They
also showed that, in comparison with microsomal
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enzymes, mitochondrial cytochrome P450s have
higher affinity for MT O-demethylation and 6-
hydroxylation2. 6-hydroxylation is mainly mediated
by cytochrome P4501A2 (CYP1A2), a high-affinity
enzyme for MT metabolism in human liver
microsome5.
Role of MT in energy production at liver
Adequate maintenance of Adenosine
triphosphate (ATP) levels is crucial for the liver cells
viability, and its depletion causes membrane
permeability derangement contributing to
irreversible cell injury6. The depletion of ATP during
ischemia leads to a loss of the transmembrane
potential of mitochondria which is associated with
overload of Ca2+ and the following mitochondrial
permeability transition (MPT) pore opening. Then
overload of ions and hyperosmotic effect cause
rapid swelling and rupture of mitochondria; as a
result, cytochrome c, at the intermembrane space,
releases into the cytosol and activates caspase 9
which in turn activates caspase 3 and the
subsequent DNA fragmentation7. Release of
cytochrome c may also due to production of NO
triggered by increased Ca2+ levels. Furthermore,
ONOO- and possibly NO inhibit respiration through
suppression of aconitase, a component of the Krebs
cycle, in both mitochondria and cytosol8.
Mitochondria are organelles in which high
concentrations of MT seem to accumulate9, 10.
Concentration of MT in the mitochondria is 100
times higher than in the blood2. MT (10 mg/kg BW)
improves hepatic injury metabolism by reduction
of the rate of mitochondrial energy transfer
suppression and restoration to near normal of
mitochondrial structure11. MT (1 nM) increases the
activity of oxidative phosphorylation and complexes
I & IV in rat liver mitochondria resulting in production
of ATP12. The capability of MT to donate and accept
electrons causes improvement of respiratory chain
activity and increase of electron flow6, 13. MT could
also detoxify electron-deficient ROS through its
electron donation ability. Furthermore, MT reduces
electron leakage and free radicals generation via
potentiation of mitochondrial electron transport
chain efficiency9. This efficiency is provided through
stabilization of mitochondrial inner membranes by
MT14. Glutamate dehydrogenase (GDH) activity is
a marker of the integrity of mitochondrial membrane.
Administration of MT (10 mg/kg) 15 min before
ischemia and immediately before reperfusion
increases the activity of GDH7.
Prevention of OS and LPO in liver by MT
OS is the consequence of redux balance
disruption10 between antioxidant and pro-oxidant
species leading to oxidative damage of cellular
macromolecules15 and is the causing factor of
aging10. These pro-oxidants are collectively known
as ROS15. Approximately, 1-2% of the consumed
oxygen by the organism at physiological level is
converted to ROS4, and under normal conditions,
antioxidant defense systems keep ROS at
physiologically optimal levels16. Different types of
ROS are considered as important mediators in
various models of tissue injury17, such as toxic
reactions, inflammation and ischemic processes18.
The excessive production of ROS results in
oxidative destruction to the deoxyribonucleic acid
(DNA), proteins, and lipids. ROS can act with the
nucleic acids attacking the nitrogenous bases and
the sugar phosphate backbone and can elicit
single- and double-stranded DNA breaks. ROS also
attack structural and enzymatic proteins by the
oxidation of residual amino acids, prosthetic
groups, formation of cross links, protein aggregates,
and proteolysis. The inactivation of the key proteins
can lead to the serious consequences in the vital
metabolic pathways. Lipid peroxidation
(autooxidation) is a process of oxidation of
polyunsaturated fatty acids due to the presence of
several double bonds in their structure and it
involves production of peroxides (chemical
compounds in which two oxygen atoms are linked
together by a single covalent bond), ROS, and other
reactive organic free radicals19. In fatty liver, the
predominant pro-oxidants are superoxide anion
(O2•–) radical, singlet oxygen, •OH and H2O2 15; ROS
are involved in damaging various essential
biological molecules including membrane lipids,
DNA and cellular proteins3. ROS are derived from
mitochondrial, microsomal and other hepatocellular
pro-oxidant pathways in the critical reduction of
antioxidant defenses15.
A major source of ROS is from the
mitochondrial electron transport chain. ROS may
be produced by other mechanisms. Radical
scavenging function of MT exerts at both
pharmacological and physiological concentrations
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and in vitro and in vivo6. MT exerts free radical
scavenging by having acetyl group on the side
chain and methoxyl group at the position five20. MT
scavenges reactive nitrogen, reactive oxygen
species (ROS)15, nitric oxide (NO) and singlet
oxygen as well as is able to repair oxidatively
damaged membrane lipids and cytosolic proteins21.
MT is also able to decrease oxygen consumption
in liver mitochondria, which results in less ROS
production22. ROS production resulting in oxidative
damage increases intracellular Ca2+ levels23. Ca2+
then enters the nucleus to activate nucleases which
cause breaks in DNA strands which to inhibited
influx of Ca2+ in cells via MT23. NF-kB activation,
protein carbonyls and TBARS are OS markers24.
NF-kB signaling activation is central to the
inflammatory response pathophysiology9. NF-kB
regulates various inflammatory genes including
iNOS, IL-6, tumor necrosis factor-α (TNF-α) and IL-
1β (9). Although IL-1 does not induce liver damage,
it could stimulate inflammatory cells to produce more
TNF-α, IL-6 and IL-8 cytokines21.  Liver is one of the
organs vulnerable to the attack of pro-inflammatory
cytokines25. Liver cells that produce pro-
inflammatory cytokines are Kupffer cells, HSCs,
BECs and endothelial sinusoid cells25. Kupffer cells
play key roles in phagocytosis, immunomodulation
and biochemical attack. These cells are activated
by damaged hepatocytes, infiltrating inflammatory
cells and toxic metabolic agents21. NF-kB is inhibits
by Nuclear erythroid 2-related factor 2 (Nrf2)9. Nrf2
is a chief transcription factor involves in regulation
of cellular antioxidative response against ROS. By
binding to antioxidant response (ARE), upon cell
stimulation, Nrf2 causes upregulation of antioxidant
enzymes, and decreases sensitivity of the cells to
OS9, 24. ARE sequence exists in the promoter region
of most of the antioxidant enzymes encoding genes.
Fig. 1: The excessive production of ROS results in oxidative destruction to the DNA, proteins,
and lipids. In contrast, NF-kB regulates various inflammatory genes including iNOS, IL-6, tumor
necrosis factor-α (TNF-α) and IL-1β. NF-kB is inhibits by Nrf2 that’s a chief transcription factor
involves in regulation of cellular antioxidative response against ROS. By binding to antioxidant
response (ARE), upon cell stimulation, Nrf2 causes upregulation of antioxidant enzymes, and
decreases sensitivity of the cells to OS. MT has immunomodulatory action, and by inhibition of
nuclear translocation of NF-kB, increasing the nuclear expression of Nrf2, alteration of redox
balance through increase of GSH levels, and scavenger of ROS
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Antioxidant enzymes gene expression regulates
by Nrf2/ARE are HO-1, quinone oxidoreductase-1
(NQO1), GST and SOD2. Nrf2 modulates acute
inflammatory responses in which Nrf2-deficient
mice show increased activation of NF-kB in
response to conditions like LPS. Nrf2 also plays a
crucial role in the cellular redox balance
maintenance9. MT has immunomodulatory action,
and by inhibition of nuclear translocation of NF-kB
and its further binding to DNA may take part in the
decrease of pro-inflammatory cytokines and
adhesion molecules24 (Figure 1) . MT also increases
the nuclear expression of Nrf2 9 and alters redox
balance through increase of GSH levels and
scavenge of ROS26. Wang et al. showed that MT
has no direct effect on suppression of Kupffer cells21.
Cell response against oxidative effects conveys
through production of heat shock proteins (HSP),
metallothionein27 and antioxidant enzymes3. HSPs
are molecular chaperons with key roles in the cell
protection against OS toxic effects. MT is a cytosolic
protein enriched in cysteine which acts as a potent
ROS scavenger, and protects the cells against
highly reactive compounds; in defense mechanisms
to toxicity, MT is regarded as a cellular detoxification
mediator of metals27. SOD and CAT are important
antioxidant enzymes and have key defensive roles
against free radicals3  so that cooperative action of
intracellular SOD, CAT and GPx is involved in liver
detoxification of ROS4. Other antioxidant enzymes
are reduced GSH, GPx13, glutathione reductase/
GRx, glucose 6-phosphate dehydrogenase,  γ-
glutamylcysteine synthase4. Glutathione
peroxidase (GPx), as the most abundant
peroxidase28, is an antioxidant enzyme involving
in metabolism of potentially damaging molecules
into non-toxic products11. Reduced GSH along with
GPx are served as the main antioxidant protection
of mitochondria, the organelle with lack of CAT for
protection; mitochondria obtain GSH from cytosol.
Chemical-induced oxidative liver injury showed
depletion of GSH in mitochondria, rather than
cytosol, for irreversible cellular damage
development, therefore, mitochondrial GSH
homeostasis is crucial for defending mitochondria
and thus the whole cell against oxidative damage13.
GSH content is an index for the cellular redox state7
in which oxidized and reduced GSH ratio (GSSG/
GSH) is a sensitive cellular redox state indicator16.
GSH plays a main role in the regulation of
intracellular ROS26. GPx and CAT reduce the levels
of hydrogen peroxide (H2O2) 28. GPx also reduces
lipid peroxide, and it is important in LPO prevention
and maintenance of the function and structure of
biological membranes15. MT scavenges H2O2,
thereby preventing the consumption of the GSH
pool within mitochondria and the subsequent
mitochondrial damage29. MT protects mitochondria
from oxidative injury through decrease of excess
Krebs’ cycle, thereby restricts overstimulation of
cellular respiration22. MT is also well-known to
regulate and/or maintain the intracellular GSH
concentration10 and promotes GSSG to GSH
conversion30. It has also been reported by Albarran
et al. that there is a presumable relation between
the MT rhythm with night time increase of SOD
activity and blood levels of antioxidants31. However,
depending upon the incubation time and
concentration, MT could exert both antioxidant and
pro-oxidant features; to explain, using MT at
concentrations of 0.1-10 µm in the human liver cell
line (HepG2) for 24 h shows antioxidant properties
through increase of GSH level, which associated
with cell viability improvement.
CONCLUSION
OS is an inducer of hepatocyte apoptosis,
which works through intrinsic apoptosis pathway.
OS and LPO potentially increases mitochondrial
membrane permeability resulting in mitochondrial
integrity loss and further cytochrome c release into
cytoplasm; then, cytochrome c joins Apaf-1 which
in turn polymerizes into apoptosome. Apoptosis can
promote by ROS generation increment or
endogenous antioxidant depletion. Liver
mitochondria of mice showed age-related reduction
in activities of complex I and IV, leading to excessive
free radical generation and less effective
mitochondrial defense against oxidative damage.
Melatonin normalizes cytochrome c content in both
cytosol and mitochondria. Melatonin also increases
bcl2 antiapoptotic levels and decreases Bax
antiapoptotic levels. The Bcl2 family is a key
regulator of the intrinsic apoptosis pathway, which
includes both antiapoptotic (bcl2 or bcl-xL) and pro-
apoptotic (Bax) proteins. Melatonin is the antagonist
of the apoptosis intrinsic pathway by alteration of
Bax/bcl2 levels mostly through its radical
scavenging function. Furthermore, melatonin-
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reperfused livers increase the area of ROS-positive
hepatocytes; interestingly, this increase of ROS
production did not augment OS to the liver
parenchyma; instead, it was in agreement with the
melatonin increase of bile production and ATP
levels. OS induction, antioxidant status depletion
and mitochondrial dysfunction are the relevant
features in liver diseases. Moreover, Nrf2 that is a
chief transcription factor involves in regulation of
cellular antioxidative response against ROS causes
upregulation of antioxidant enzymes, and
decreases sensitivity of the cells to OS.
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